Thermo Electron Acquires Provider of Continuous Air Quality Monitoring Instruments

Apr. 27, 2005

WALTHAM, Mass., April 27 /PRNewswire-FirstCall/ -- Thermo Electron Corporation (NYSE: TMO) announced today that it has purchased Rupprecht and Patashnick Co., Inc. (R&P), a leader in continuous particulate monitoring instrumentation for the ambient air, emissions monitoring and industrial hygiene markets. The company had 2004 revenues of $17 million. The financial terms of the transaction were not disclosed.

Marijn E. Dekkers, president and chief executive officer of Thermo Electron said, "R&P is well positioned to address future particulate monitoring regulations that will impact the emissions and ambient air monitoring markets, both of which are core to Thermo. Their product offering is an excellent complement to our existing portfolio of gas analyzers and particulate monitoring instruments, and will significantly enhance Thermo's global position in these markets by creating a supplier with a strong portfolio of instrumentation and service capabilities. The R&P acquisition strengthens our ability to meet our customers' current and future compliance, health and safety needs and reinforces our commitment to be the world leader in analytical instrumentation for environmental applications."

Since its formation in 1981, R&P has established a global reputation for developing innovative and reliable high performance instrumentation designed to meet the most demanding regulatory applications for continuous particulate monitoring. Headquartered in East Greenbush, New York, R&P will become part of the Air Quality Instruments product line within Thermo's Environmental Instruments division.

About Thermo Electron

Thermo Electron Corporation is the world leader in analytical instruments. Our instrument solutions enable our customers to make the world a healthier, cleaner and safer place. Thermo's Life and Laboratory Sciences segment provides analytical instruments, scientific equipment, services and software solutions for life science, drug discovery, clinical, environmental and industrial laboratories. Thermo's Measurement and Control segment is dedicated to providing analytical instruments used in a variety of manufacturing processes and in-the-field applications, including those associated with safety and homeland security. Based near Boston, Massachusetts, Thermo has revenues of more than $2 billion, and employs approximately 10,000 people in 30 countries. For more information, visit http://www.thermo.com.

The following constitutes a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward- looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth under the heading "Forward-Looking Statements" in the company's Annual Report in the Form 10-K for the fiscal year ended December 31, 2004. These include risks and uncertainties relating to: the need to develop new products and adapt to significant technological change, dependence on customers that operate in cyclical industries, general worldwide economic conditions and related uncertainties, the effect of changes in governmental regulations, dependence on customers' capital spending policies and government funding policies, use and protection of intellectual property, exposure to product liability claims in excess of insurance coverage, retention of contingent liabilities from businesses we sold, realization of potential future savings from new productivity initiatives, implementation of new branding strategy, implementation of strategies for improving internal growth, the effect of exchange rate fluctuations on international operations, identification, completion and integration of new acquisitions and potential impairment of goodwill from previous acquisitions. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

     Media Contact Information:              Investor Contact  Information:
     Lori Gorski                             J. Timothy Corcoran
     Phone:    781-622-1242                  Phone:    781-622-1111
     E-mail:   lori.gorski@thermo.com        E-mail:   tim.corcoran@thermo.com
     Website:  http://www.thermo.com

SOURCE Thermo Electron Corporation 
04/27/2005

CONTACT: Media Contact Information: Lori Gorski, +1-781-622-1242, lori.gorski@thermo.com; or Investor Contact Information: J. Timothy Corcoran, +1-781-622-1111, tim.corcoran@thermo.com

Web site: http://www.thermo.com
(TMO)

Thermo Fisher Scientific At a Glance

More than $20 billion in annual revenue and

70,000 Employees

Premier Brands

– Thermo Scientific

– Applied Biosystems

– Invitrogen

– Fisher Scientific

– Unity Lab Services

Read more

NYSE: TMO (Common Stock)Oct 16, 2018 04:01 PM

Exchange NYSE (US Dollar)NYSE

Price 235.15

Change +7.05  (+3.09%)

Volume 2,034,362

% Change

Intraday High 235.66

52 Week High 249.95

Intraday Low 229.97

52 Week Low 181.51

Today's Open 230.70

Previous Close 228.10

Minimum 20 minute delay

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit http://www.thermofisher.com.

The world leader in serving science